<DOC>
	<DOC>NCT02604264</DOC>
	<brief_summary>To assess positive blood cultures (PBCs) in hemodialysis central venous catheter (CVC) patients using two FDA cleared devices: ClearGuard HD end caps compared to conventional end caps.</brief_summary>
	<brief_title>Product Evaluation for the Effectiveness of the ClearGuardâ„¢ HD End Cap</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<criteria>All patients dialyzing with a central venous catheter Known allergy to chlorhexidine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>